|Place of Origin:||China|
|Model Number:||Film coated Tablets, 150mg, 200mg|
|Minimum Order Quantity:||100, 000 tablets|
|Payment Terms:||L/C, T/T|
|Supply Ability:||One million pills per day|
|Product:||Faropenem Sodium Tablets||Specification:||Film Coated Tablets, 150mg, 200mg|
Faropenem Sodium Tablets Film coated Tablets, 150mg, 200mg Oral Medications Antibiotics
Product : Faropenem Sodium Tablets
Specification : Film coated Tablets, 150mg, 200mg
Standard : BP, USP
Packing : 10’s/blister
Investigated for use/treatment in bacterial infection, bronchitis, otitis media, and pediatric indications.
Faropenem has demonstrated excellent in vitro activity against common respiratory pathogens, many aerobic gram-positive organisms, and anaerobes. Activity against gram-negative organisms is more reserved. In vivo data suggest that faropenem is efficacious in treating community-acquired infections including uncomplicated skin and skin structure infections; however, more data may help to characterize faropenem's place in antimicrobial therapy.
Mechanism of action
Like other beta-lactam antibiotics, faropenem acts by inhibiting the synthesis of bacterial cell walls. It inhibits cross-linkage between the linear peptidoglycan polymer chains that make up a major component of the cell wall of Gram-positive bacteria. It does this by binding to and competitively inhibiting the transpeptidase enzyme used by bacteria to cross-link the peptide (D-alanyl-alanine) used in peptidogylcan synthesis.